Breaking Nigeria Kicks Off Presidential Campaigns Amidst Economic and Security Challenges Unitree’s Stock Soars 629% on Shanghai Debut, Raising $904 Million Ukraine Targets Logistics Hub Near Moscow with Drone Attack First US Jellyfish Museum Opens in Pompano Beach, Florida Brewers Tie Modern-Era Record with Dominant 22-0 Shutout Victory Over Mariners

Wednesday August 19, 2026

Section

PRNewswire

Press Release

VIA Investors Have Opportunity to Lead Via Transportation, Inc. Securities Lawsuit

THE ROSEN LAW FIRM, P. A. · Jul 6

Press Release

Are AVB, LPRO, APGE, TMHC Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLP · Jul 6

Press Release

Aureka Releases OpenDDE, an Open-Source Drug Discovery Engine Designed to Accelerate AI-Driven Therapeutic Discovery

Aureka · Jul 6

Press Release

Are ESI, INM, HUN, OLN Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLP · Jul 6

Press Release

ESHRE 42nd Annual Meeting: Halving fertility treatment costs could more than double births, major global study shows

ESHRE 42nd Annual Meeting · Jul 6

Press Release

Rosen Law Firm Encourages Alarum Technologies Ltd. Investors to Inquire About Securities Class Action Investigation – ALAR

THE ROSEN LAW FIRM, P. A. · Jul 6

Press Release

ZETA PHI BETA SORORITY, INCORPORATED TO CONVENE THOUSANDS IN NASHVILLE FOR 2026 GRAND BOULÉ

Zeta Phi Beta Sorority, Inc. · Jul 6

Press Release

SIGGRAPH 2026 Announces Sponsored Keynote Presentations Showcasing the Future of Graphics, AI, and Simulation

SIGGRAPH 2026 · Jul 6

Press Release

American Packaging Corporation Brings Performance and Visibility to Frozen Food Packaging

American Packaging Corporation · Jul 6

Press Release

Active Motif Announces Exclusive Global Distribution Agreement with Arima Genomics for Advanced 3D Genomics Solutions

Active Motif · Jul 6

Press Release

We Have Until LA28 to Stop Renting Attention

della · Jul 6

Press Release

VineBrook Homes Trust Announces Cancellation of Annual Meeting of Stockholders

VineBrook Homes Trust, Inc. · Jul 6

Press Release

AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulatory Agency and Health Canada

AMO Pharma Limited · Jul 6

← Previous 1 … 853 854 855 … 933 Next →